Publisher: Medknow Publishers   (Total: 427 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 427 Journals sorted alphabetically
Acta Medica Intl.     Open Access   (SJR: 0.101, CiteScore: 0)
Advanced Arab Academy of Audio-Vestibulogy J.     Open Access  
Advanced Biomedical Research     Open Access  
Advances in Human Biology     Open Access   (Followers: 5)
Advances in Skeletal Muscle Function Assessment     Open Access  
African J. for Infertility and Assisted Conception     Open Access   (Followers: 1)
African J. of Medical and Health Sciences     Open Access   (Followers: 3)
African J. of Paediatric Surgery     Open Access   (Followers: 7, SJR: 0.25, CiteScore: 1)
African J. of Trauma     Open Access   (Followers: 1)
Ain-Shams J. of Anaesthesiology     Open Access   (Followers: 2)
Al-Azhar Assiut Medical J.     Open Access   (Followers: 2)
Al-Basar Intl. J. of Ophthalmology     Open Access   (Followers: 1)
Alexandria J. of Pediatrics     Open Access   (Followers: 1)
Ancient Science of Life     Open Access   (Followers: 5)
Anesthesia : Essays and Researches     Open Access   (Followers: 10)
Annals of African Medicine     Open Access   (Followers: 2, SJR: 0.258, CiteScore: 1)
Annals of Bioanthropology     Open Access   (Followers: 5)
Annals of Cardiac Anaesthesia     Open Access   (Followers: 15, SJR: 0.308, CiteScore: 1)
Annals of Indian Academy of Neurology     Open Access   (Followers: 3, SJR: 0.434, CiteScore: 1)
Annals of Indian Academy of Otorhinolaryngology Head and Neck Surgery     Open Access  
Annals of Indian Psychiatry     Open Access  
Annals of Maxillofacial Surgery     Open Access   (Followers: 6)
Annals of Medical and Health Sciences Research     Open Access   (Followers: 7)
Annals of Nigerian Medicine     Open Access   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 12, SJR: 0.352, CiteScore: 1)
Annals of Saudi Medicine     Open Access   (SJR: 0.238, CiteScore: 1)
Annals of Thoracic Medicine     Open Access   (Followers: 6, SJR: 0.524, CiteScore: 1)
Annals of Tropical Medicine and Public Health     Open Access   (Followers: 14, SJR: 0.152, CiteScore: 0)
Annals of Tropical Pathology     Open Access  
Apollo Medicine     Open Access  
APOS Trends in Orthodontics     Open Access   (Followers: 1)
Arab J. of Interventional Radiology     Open Access   (Followers: 1)
Archives of Cardiovascular Imaging     Open Access   (Followers: 2, SJR: 0.187, CiteScore: 0)
Archives of Intl. Surgery     Open Access   (Followers: 10, SJR: 0.302, CiteScore: 1)
Archives of Medicine and Health Sciences     Open Access   (Followers: 5)
Archives of Medicine and Surgery     Open Access   (Followers: 1)
Archives of Pharmacy Practice     Open Access   (Followers: 12, SJR: 0.102, CiteScore: 0)
Archives of Trauma Research     Open Access   (Followers: 4, SJR: 0.37, CiteScore: 2)
Asia Pacific J. of Clinical Trials : Nervous System Diseases     Open Access   (Followers: 1)
Asia-Pacific J. of Oncology Nursing     Open Access   (Followers: 5)
Asian J. of Andrology     Open Access   (Followers: 1, SJR: 0.856, CiteScore: 2)
Asian J. of Neurosurgery     Open Access   (Followers: 2)
Asian J. of Oncology     Open Access   (Followers: 2)
Asian J. of Transfusion Science     Open Access   (Followers: 1, SJR: 0.35, CiteScore: 1)
Asian Pacific J. of Reproduction     Open Access   (SJR: 0.227, CiteScore: 1)
Asian Pacific J. of Tropical Biomedicine     Open Access   (Followers: 2, SJR: 0.491, CiteScore: 2)
Asian Pacific J. of Tropical Medicine     Open Access   (Followers: 1, SJR: 0.561, CiteScore: 2)
Astrocyte     Open Access  
Avicenna J. of Medicine     Open Access   (Followers: 1)
AYU : An international quarterly journal of research in Ayurveda     Open Access   (Followers: 6)
Benha Medical J.     Open Access  
Biomedical and Biotechnology Research J.     Open Access   (Followers: 1)
BLDE University J. of Health Sciences     Open Access  
Brain Circulation     Open Access   (Followers: 1)
Bulletin of Faculty of Physical Therapy     Open Access   (Followers: 2)
Canadian J. of Rural Medicine     Full-text available via subscription   (Followers: 1, SJR: 0.202, CiteScore: 0)
Cancer Translational Medicine     Open Access   (Followers: 2)
Cardiology Plus     Open Access   (Followers: 1)
Chinese Medical J.     Open Access   (Followers: 10, SJR: 0.52, CiteScore: 1)
CHRISMED J. of Health and Research     Open Access   (Followers: 2)
Clinical Cancer Investigation J.     Open Access  
Clinical Dermatology Review     Open Access   (Followers: 5)
Clinical Trials in Degenerative Diseases     Open Access  
Clinical Trials in Orthopedic Disorders     Open Access   (Followers: 2)
Community Acquired Infection     Open Access  
Conservation and Society     Open Access   (Followers: 10, SJR: 0.811, CiteScore: 2)
Contemporary Clinical Dentistry     Open Access   (Followers: 5, SJR: 0.353, CiteScore: 1)
Current Medical Issues     Open Access   (Followers: 2)
CytoJ.     Open Access   (Followers: 3, SJR: 0.543, CiteScore: 1)
Delta J. of Ophthalmology     Open Access  
Dental Hypotheses     Open Access   (Followers: 5, SJR: 0.152, CiteScore: 0)
Dental Research J.     Open Access   (Followers: 14, SJR: 0.416, CiteScore: 1)
Dentistry and Medical Research     Open Access   (Followers: 1)
Digital Medicine     Open Access  
Drug Development and Therapeutics     Open Access  
Education for Health     Open Access   (Followers: 8, SJR: 0.242, CiteScore: 0)
Education in the Health Professions     Open Access   (Followers: 2)
Egyptian J. of Bronchology     Open Access  
Egyptian J. of Cardiothoracic Anesthesia     Open Access  
Egyptian J. of Cataract and Refractive Surgery     Open Access   (Followers: 1, SJR: 1.799, CiteScore: 2)
Egyptian J. of Chest Diseases and Tuberculosis     Open Access   (Followers: 3, SJR: 0.155, CiteScore: 0)
Egyptian J. of Dermatology and Venerology     Open Access   (Followers: 1)
Egyptian J. of Haematology     Open Access   (Followers: 1)
Egyptian J. of Internal Medicine     Open Access   (Followers: 1)
Egyptian J. of Obesity, Diabetes and Endocrinology     Open Access   (Followers: 1)
Egyptian J. of Otolaryngology     Open Access   (Followers: 2)
Egyptian J. of Psychiatry     Open Access   (Followers: 1)
Egyptian J. of Surgery     Open Access   (Followers: 1)
Egyptian Nursing J.     Open Access  
Egyptian Orthopaedic J.     Open Access   (Followers: 2)
Egyptian Pharmaceutical J.     Open Access   (Followers: 3)
Egyptian Retina J.     Open Access  
Egyptian Rheumatology and Rehabilitation     Open Access   (Followers: 2)
Endodontology     Open Access  
Endoscopic Ultrasound     Open Access   (SJR: 0.822, CiteScore: 2)
Environmental Disease     Open Access   (Followers: 4)
Eurasian J. of Pulmonology     Open Access  
European J. of Dentistry     Open Access   (Followers: 4, SJR: 0.749, CiteScore: 2)
European J. of General Dentistry     Open Access   (Followers: 2, SJR: 0.12, CiteScore: 0)
European J. of Prosthodontics     Open Access   (Followers: 4)
European J. of Psychology and Educational Studies     Open Access   (Followers: 11, SJR: 0.113, CiteScore: 0)
Fertility Science and Research     Open Access  
Formosan J. of Surgery     Open Access   (SJR: 0.112, CiteScore: 0)
Genome Integrity     Open Access   (Followers: 2, SJR: 0.153, CiteScore: 0)
Glioma     Open Access  
Global J. of Transfusion Medicine     Open Access   (Followers: 1)
Gynecology and Minimally Invasive Therapy     Open Access   (SJR: 0.311, CiteScore: 1)
Hamdan Medical J.     Open Access  
Heart and Mind     Open Access  
Heart India     Open Access   (Followers: 2)
Heart Views     Open Access   (Followers: 2)
Hepatitis B Annual     Open Access   (Followers: 3)
Ibnosina J. of Medicine and Biomedical Sciences     Open Access   (Followers: 1)
IJS Short Reports     Open Access  
Imam J. of Applied Sciences     Open Access  
Indian Dermatology Online J.     Open Access   (Followers: 3)
Indian J. of Allergy, Asthma and Immunology     Open Access   (Followers: 1)
Indian J. of Anaesthesia     Open Access   (Followers: 7, SJR: 0.478, CiteScore: 1)
Indian J. of Burns     Open Access   (Followers: 3)
Indian J. of Cancer     Open Access   (Followers: 1, SJR: 0.361, CiteScore: 1)
Indian J. of Cerebral Palsy     Open Access   (Followers: 1)
Indian J. of Community Medicine     Open Access   (Followers: 2, SJR: 0.37, CiteScore: 1)
Indian J. of Dental Research     Open Access   (Followers: 5, SJR: 0.266, CiteScore: 1)
Indian J. of Dental Sciences     Open Access  
Indian J. of Dentistry     Open Access   (Followers: 1)
Indian J. of Dermatology     Open Access   (Followers: 2, SJR: 0.468, CiteScore: 1)
Indian J. of Dermatology, Venereology and Leprology     Open Access   (Followers: 4, SJR: 0.445, CiteScore: 1)
Indian J. of Dermatopathology and Diagnostic Dermatology     Open Access  
Indian J. of Drugs in Dermatology     Open Access   (Followers: 1, SJR: 0.791, CiteScore: 1)
Indian J. of Endocrinology and Metabolism     Open Access   (Followers: 4, SJR: 0.568, CiteScore: 1)
Indian J. of Health Sciences and Biomedical Research KLEU     Open Access   (Followers: 3)
Indian J. of Medical and Paediatric Oncology     Open Access   (SJR: 0.425, CiteScore: 1)
Indian J. of Medical Microbiology     Open Access   (Followers: 2, SJR: 0.503, CiteScore: 1)
Indian J. of Medical Research     Open Access   (Followers: 4, SJR: 0.656, CiteScore: 1)
Indian J. of Medical Sciences     Open Access   (Followers: 3, SJR: 0.102, CiteScore: 0)
Indian J. of Multidisciplinary Dentistry     Open Access   (Followers: 1)
Indian J. of Nephrology     Open Access   (Followers: 2, SJR: 0.347, CiteScore: 1)
Indian J. of Nuclear Medicine     Open Access   (Followers: 2, SJR: 0.23, CiteScore: 0)
Indian J. of Occupational and Environmental Medicine     Open Access   (Followers: 3, SJR: 0.225, CiteScore: 1)
Indian J. of Ophthalmology     Open Access   (Followers: 5, SJR: 0.498, CiteScore: 1)
Indian J. of Oral Health and Research     Open Access  
Indian J. of Oral Sciences     Open Access   (Followers: 1)
Indian J. of Orthopaedics     Open Access   (Followers: 8, SJR: 0.392, CiteScore: 1)
Indian J. of Otology     Open Access   (Followers: 1, SJR: 0.199, CiteScore: 0)
Indian J. of Paediatric Dermatology     Open Access   (Followers: 2)
Indian J. of Pain     Open Access   (Followers: 2)
Indian J. of Palliative Care     Open Access   (Followers: 8, SJR: 0.454, CiteScore: 1)
Indian J. of Pathology and Microbiology     Open Access   (Followers: 4, SJR: 0.276, CiteScore: 1)
Indian J. of Pharmacology     Open Access   (SJR: 0.412, CiteScore: 1)
Indian J. of Psychiatry     Open Access   (Followers: 2, SJR: 0.408, CiteScore: 1)
Indian J. of Psychological Medicine     Open Access   (SJR: 0.368, CiteScore: 1)
Indian J. of Public Health     Open Access   (Followers: 1)
Indian J. of Radiology and Imaging     Open Access   (Followers: 5)
Indian J. of Research in Homoeopathy     Open Access   (Followers: 2)
Indian J. of Respiratory Care     Open Access   (Followers: 3)
Indian J. of Rheumatology     Open Access   (Followers: 1, SJR: 0.119, CiteScore: 0)
Indian J. of Sexually Transmitted Diseases and AIDS     Open Access   (Followers: 2, SJR: 0.34, CiteScore: 0)
Indian J. of Social Psychiatry     Open Access   (Followers: 1)
Indian J. of Transplantation     Open Access  
Indian J. of Urology     Open Access   (Followers: 5, SJR: 0.434, CiteScore: 1)
Indian J. of Vascular and Endovascular Surgery     Open Access   (Followers: 2)
Indian Spine J.     Open Access  
Industrial Psychiatry J.     Open Access   (Followers: 2)
Intervention     Open Access   (Followers: 2)
Intl. Archives of Health Sciences     Open Access  
Intl. J. of Abdominal Wall and Hernia Surgery     Open Access   (Followers: 1)
Intl. J. of Academic Medicine     Open Access  
Intl. J. of Advanced Medical and Health Research     Open Access  
Intl. J. of Applied and Basic Medical Research     Open Access  
Intl. J. of Clinical and Experimental Physiology     Open Access   (Followers: 1)
Intl. J. of Clinicopathological Correlation     Open Access   (Followers: 1)
Intl. J. of Community Dentistry     Open Access  
Intl. J. of Critical Illness and Injury Science     Open Access   (Followers: 1, SJR: 0.192, CiteScore: 0)
Intl. J. of Educational and Psychological Researches     Open Access   (Followers: 4)
Intl. J. of Environmental Health Engineering     Open Access   (Followers: 1)
Intl. J. of Forensic Odontology     Open Access   (Followers: 1)
Intl. J. of Green Pharmacy     Open Access   (Followers: 8, SJR: 0.142, CiteScore: 0)
Intl. J. of Growth Factors and Stem Cells in Dentistry     Open Access  
Intl. J. of Health & Allied Sciences     Open Access   (Followers: 3)
Intl. J. of Health System and Disaster Management     Open Access   (Followers: 3)
Intl. J. of Heart Rhythm     Open Access  
Intl. J. of Medicine and Public Health     Open Access   (Followers: 6)
Intl. J. of Mycobacteriology     Open Access   (SJR: 0.535, CiteScore: 1)
Intl. J. of Noncommunicable Diseases     Open Access  
Intl. J. of Nutrition, Pharmacology, Neurological Diseases     Open Access   (Followers: 4, SJR: 0.17, CiteScore: 0)
Intl. J. of Oral Health Sciences     Open Access   (Followers: 3)
Intl. J. of Orofacial Biology     Open Access   (Followers: 1)
Intl. J. of Orofacial Research     Open Access   (Followers: 2)
Intl. J. of Orthodontic Rehabilitation     Open Access   (Followers: 2)
Intl. J. of Pedodontic Rehabilitation     Open Access  
Intl. J. of Pharmaceutical Investigation     Open Access   (Followers: 2)
Intl. J. of Preventive Medicine     Open Access   (Followers: 1, SJR: 0.623, CiteScore: 1)
Intl. J. of Shoulder Surgery     Open Access   (Followers: 5, SJR: 0.653, CiteScore: 1)
Intl. J. of the Cardiovascular Academy     Open Access   (SJR: 0.105, CiteScore: 0)
Intl. J. of Trichology     Open Access   (SJR: 0.4, CiteScore: 1)
Intl. J. of Yoga     Open Access   (Followers: 16)
Intl. J. of Yoga : Philosophy, Psychology and Parapsychology     Open Access   (Followers: 7)
Iranian J. of Nursing and Midwifery Research     Open Access   (Followers: 3)
Iraqi J. of Hematology     Open Access  
J. of Academy of Medical Sciences     Open Access  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Indian Journal of Medical Research
Journal Prestige (SJR): 0.656
Citation Impact (citeScore): 1
Number of Followers: 4  

  This is an Open Access Journal Open Access journal
ISSN (Print) 0971-5916
Published by Medknow Publishers Homepage  [427 journals]
  • Lessons learnt during the first 100 days of COVID-19 pandemic in India

    • Authors: Rajesh Bhatia, Priya Abraham
      Pages: 387 - 391
      Abstract: Rajesh Bhatia, Priya Abraham
      Indian Journal of Medical Research 2020 151(5):387-391

      Citation: Indian Journal of Medical Research 2020 151(5):387-391
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1925_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Contact lens use at the time of SARS-CoV-2 pandemic for healthcare workers

    • Authors: Raghav Bhargava
      Pages: 392 - 394
      Abstract: Raghav Bhargava
      Indian Journal of Medical Research 2020 151(5):392-394

      Citation: Indian Journal of Medical Research 2020 151(5):392-394
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1492_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Impact of COVID-19 pandemic on health system & Sustainable
           Development Goal 3

    • Authors: Sonalini Khetrapal, Rajesh Bhatia
      Pages: 395 - 399
      Abstract: Sonalini Khetrapal, Rajesh Bhatia
      Indian Journal of Medical Research 2020 151(5):395-399

      Citation: Indian Journal of Medical Research 2020 151(5):395-399
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1920_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Clinical management of COVID-19

    • Authors: George M Varghese, Rebecca John, Abi Manesh, Rajiv Karthik, OC Abraham
      Pages: 401 - 410
      Abstract: George M Varghese, Rebecca John, Abi Manesh, Rajiv Karthik, OC Abraham
      Indian Journal of Medical Research 2020 151(5):401-410
      The novel coronavirus disease 2019 (COVID-19) with its early origin from Wuhan city in China has evolved into a global pandemic. Maximal precautionary measures and resources have been put forward by most nations in war footing to mitigate transmission and decrease fatality rates. This article was aimed to review the evidence on clinical management and to deal with the identification of high-risk groups, warning signs, appropriate investigations, proper sample collection for confirmation, general and specific treatment measures, strategies as well as infection control in the healthcare settings. Advanced age, cardiovascular disease, diabetes, hypertension and cancer have been found to be the risk factors for severe disease. Fever lasting for >five days with tachypnoea, tachycardia or hypotension are indications for urgent attention and hospitalization in a patient with suspected COVID-19. At present, reverse transcription-polymerase chain reaction (RT-PCR) from the upper respiratory tract samples is the diagnostic test of choice. While many drugs have shown in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are insufficient clinical data to promote or dissuade their usage. Among the currently available drugs, hydroxychloroquine and lopinavir/ritonavir may be considered for patients with severe COVID-19 infection, awaiting further clinical trials. Stringent droplet and contact precautions will protect healthcare workers against most clinical exposures to COVID-19.
      Citation: Indian Journal of Medical Research 2020 151(5):401-410
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_957_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • COVID-19 pandemic from an ophthalmology point of view

    • Authors: Parul Chawla Gupta, M Praveen Kumar, Jagat Ram
      Pages: 411 - 418
      Abstract: Parul Chawla Gupta, M Praveen Kumar, Jagat Ram
      Indian Journal of Medical Research 2020 151(5):411-418
      Coronavirus disease 2019 (COVID-19) is caused by a highly contagious RNA virus termed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ophthalmologists are at high-risk due to their proximity and short working distance at the time of slit-lamp examination. Eye care professionals can be caught unaware because conjunctivitis may be one of the first signs of COVID-19 at presentation, even precluding the emergence of additional symptoms such as dry cough and anosmia. Breath and eye shields as well as N95 masks, should be worn while examining patients with fever, breathlessness, or any history of international travel or travel from any hotspot besides maintaining hand hygiene. All elective surgeries need to be deferred. Adults or children with sudden-onset painful or painless visual loss, or sudden-onset squint, or sudden-onset floaters or severe lid oedema need a referral for urgent care. Patients should be told to discontinue contact lens wear if they have any symptoms of COVID-19. Cornea retrieval should be avoided in confirmed cases and suspects, and long-term preservation medium for storage of corneas should be encouraged. Retinal screening is unnecessary for coronavirus patients taking chloroquine or hydroxychloroquine as the probability of toxic damage to the retina is less due to short-duration of drug therapy. Tele-ophthalmology and artificial intelligence should be preferred for increasing doctor-patient interaction.
      Citation: Indian Journal of Medical Research 2020 151(5):411-418
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1369_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • National sero-surveillance to monitor the trend of SARS-CoV-2 infection
           transmission in India: Protocol for community-based surveillance

    • Authors: Muthusamy Santhosh Kumar, Tarun Bhatnagar, Ponnaiah Manickam, V Saravana Kumar, Kiran Rade, Naman Shah, Shashi Kant, Giridhara R Babu, Sanjay Zodpey, CP Girish Kumar, Jeromie Wesley Vivian Thangaraj, Pranab Chatterjee, Suman Kanungo, Ravindra Mohan Pandey, Manoj Murhekar, Sujeet K Singh, Swarup Sarkar, JP Muliyi, Raman R Gangakhedkar, D.C.S Reddy
      Pages: 419 - 423
      Abstract: Muthusamy Santhosh Kumar, Tarun Bhatnagar, Ponnaiah Manickam, V Saravana Kumar, Kiran Rade, Naman Shah, Shashi Kant, Giridhara R Babu, Sanjay Zodpey, CP Girish Kumar, Jeromie Wesley Vivian Thangaraj, Pranab Chatterjee, Suman Kanungo, Ravindra Mohan Pandey, Manoj Murhekar, Sujeet K Singh, Swarup Sarkar, JP Muliyi, Raman R Gangakhedkar, D.C.S Reddy
      Indian Journal of Medical Research 2020 151(5):419-423
      Conducting population-based serosurveillance for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) will estimate and monitor the trend of infection in the adult general population, determine the socio-demographic risk factors and delineate the geographical spread of the infection. For this purpose, a serial cross-sectional survey would be conducted with a sample size of 24,000 distributed equally across four strata of districts categorized on the basis of the incidence of reported cases of COVID-19. Sixty districts will be included in the survey. Simultaneously, the survey will be done in 10 high-burden hotspot cities. ELISA-based antibody tests would be used. Data collection will be done using a mobile-based application. Prevalence from the group of districts in each of the four strata will be pooled to estimate the population prevalence of COVID-19 infection, and similarly for the hotspot cities, after adjusting for demographic characteristics and antibody test performance. The total number of reported cases in the districts and hotspot cities will be adjusted using this seroprevalence to estimate the expected number of infected individuals in the area. Such serosurveys repeated at regular intervals can also guide containment measures in respective areas. State-specific context of disease burden, priorities and resources should guide the use of multifarious surveillance options for the current COVID-19 epidemic.
      Citation: Indian Journal of Medical Research 2020 151(5):419-423
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1818_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Laboratory surveillance for SARS-CoV-2 in India: Performance of testing
           & descriptive epidemiology of detected COVID-19, January 22 - April
           30, 2020

    • Authors: ICMR COVID Study Group, COVID Epidemiology & Data Management Team, COVID Laboratory Team, VRDLN Team
      Pages: 424 - 437
      Abstract: ICMR COVID Study Group, COVID Epidemiology & Data Management Team, COVID Laboratory Team, VRDLN Team
      Indian Journal of Medical Research 2020 151(5):424-437
      Background & objectives: India has been reporting the cases of coronavirus disease 2019 (COVID-19) since January 30, 2020. The Indian Council of Medical Research (ICMR) formulated and established laboratory surveillance for COVID-19. In this study, an analysis of the surveillance data was done to describe the testing performance and descriptive epidemiology of COVID-19 cases by time, place and person.Methods: The data were extracted from January 22 to April 30, 2020. The frequencies of testing performance were described over time and by place. We described cases by time (epidemic curve by date of specimen collection; seven-day moving average), place (area map) and person (attack rate by age, sex and contact status), and trends were represented along with public health measures and events.Results: Between January 22 and April 30, 2020, a total of 1,021,518 individuals were tested for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Testing increased from about 250 individuals per day in the beginning of March to 50,000 specimens per day by the end of April 2020. Overall, 40,184 (3.9%) tests were reported positive. The proportion of positive cases was highest among symptomatic and asymptomatic contacts, 2-3-fold higher than among those with severe acute respiratory infection, or those with an international travel history or healthcare workers. The attack rate (per million) by age was highest among those aged 50-69 yr (63.3) and was lowest among those under 10 yr (6.1). The attack rate was higher among males (41.6) than females (24.3). The secondary attack rate was 6.0 per cent. Overall, 99.0 per cent of 736 districts reported testing and 71.1 per cent reported COVID-19 cases.Interpretation & conclusions: The coverage and frequency of ICMR's laboratory surveillance for SARS-CoV-2 improved over time. COVID-19 was reported from most parts of India, and the attack rate was more among men and the elderly and common among close contacts. Analysis of the data indicates that for further insight, additional surveillance tools and strategies at the national and sub-national levels are needed.
      Citation: Indian Journal of Medical Research 2020 151(5):424-437
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1896_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • A cluster of SARS-CoV-2 infection among Italian tourists visiting India,
           March 2020

    • Authors: Jeromie Wesley Vivian Thangaraj, Manoj Murhekar, Yatin Mehta, Sushila Kataria, Megha Brijwal, Nitesh Gupta, Aashish Choudhary, Bharati Malhotra, Madhavi Vyas, Himanshu Sharma, Naveen Yadav, Tarun Bhatnagar, Nivedita Gupta, Lalit Dar, Raman R Gangakhedkar, Balram Bhargava
      Pages: 438 - 443
      Abstract: Jeromie Wesley Vivian Thangaraj, Manoj Murhekar, Yatin Mehta, Sushila Kataria, Megha Brijwal, Nitesh Gupta, Aashish Choudhary, Bharati Malhotra, Madhavi Vyas, Himanshu Sharma, Naveen Yadav, Tarun Bhatnagar, Nivedita Gupta, Lalit Dar, Raman R Gangakhedkar, Balram Bhargava
      Indian Journal of Medical Research 2020 151(5):438-443
      Background & objectives: A cluster of SARS-CoV-2 infection occurred among Italian tourists visiting India. We report here the epidemiological, clinical, radiological and laboratory findings of the first cluster of SARS-CoV-2 infection among the tourists.Methods: Information was collected on demographic details, travel and exposure history, comorbidities, timelines of events, date of symptom onset and duration of hospitalization from the 16 Italian tourists and an Indian with laboratory-confirmed SARS-CoV-2 infection. The clinical, laboratory, radiologic and treatment data was abstracted from their medical records and all tourists were followed up till their recovery or discharge or death. Throat and deep nasal swab specimens were collected on days 3, 8, 15, 18, 23 and 25 to evaluate viral clearance.Results: A group of 23 Italian tourists reached New Delhi, India, on February 21, 2020 and along with three Indians visited several tourist places in Rajasthan. By March 3, 2020, 17 of the 26 (attack rate: 65.4%) had become positive for SARS-CoV-2 infection. Of these 17 patients, nine were symptomatic, while eight did not show any symptoms. Of the nine who developed symptoms, six were mild, one was severe and two were critically ill. The median duration between the day of confirmation for COVID-19 and RT-PCR negativity was 18 days (range: 12-23 days). Two patients died with a case fatality of 11.8 per cent.Interpretation & conclusions: This study reconfirms higher rates of transmission among close contacts and therefore, public health measures such as physical distancing, personal hygiene and infection control measures are necessary to prevent transmission.
      Citation: Indian Journal of Medical Research 2020 151(5):438-443
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1722_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2
           IgG

    • Authors: Gajanan Sapkal, Anita Shete-Aich, Rajlaxmi Jain, Pragya D Yadav, Prasad Sarkale, Rajen Lakra, Srikant Baradkar, Gururaj Rao Deshpande, Deepak Mali, Bipin N Tilekar, Triparna Majumdar, Himanshu Kaushal, Yogesh Gurav, Nivedita Gupta, Sreelekshmy Mohandas, Ketki Deshpande, Ojas Kaduskar, Malvika Salve, Savita Patil, Shivshankar Gaikwad, AP Sugunan, M Ashok, Sidhartha Giri, Jayanthi Shastri, Priya Abraham, Raman R Gangakhedkar, COVID Support Team
      Pages: 444 - 449
      Abstract: Gajanan Sapkal, Anita Shete-Aich, Rajlaxmi Jain, Pragya D Yadav, Prasad Sarkale, Rajen Lakra, Srikant Baradkar, Gururaj Rao Deshpande, Deepak Mali, Bipin N Tilekar, Triparna Majumdar, Himanshu Kaushal, Yogesh Gurav, Nivedita Gupta, Sreelekshmy Mohandas, Ketki Deshpande, Ojas Kaduskar, Malvika Salve, Savita Patil, Shivshankar Gaikwad, AP Sugunan, M Ashok, Sidhartha Giri, Jayanthi Shastri, Priya Abraham, Raman R Gangakhedkar, COVID Support Team
      Indian Journal of Medical Research 2020 151(5):444-449
      Background & objectives: Since the beginning of the year 2020, the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted humankind adversely in almost all spheres of life. The virus belongs to the genus Betacoronavirus of the family Coronaviridae. SARS-CoV-2 causes the disease known as coronavirus disease 2019 (COVID-19) with mild-to-severe respiratory illness. The currently available diagnostic tools for the diagnosis of COVID-19 are mainly based on molecular assays. Real-time reverse transcription-polymerase chain reaction is the only diagnostic method currently recommended by the World Health Organization for COVID-19. With the rapid spread of SARS-CoV-2, it is necessary to utilize other tests, which would determine the burden of the disease as well as the spread of the outbreak. Considering the need for the development of such a screening test, an attempt was made to develop and evaluate an IgG-based ELISA for COVID-19. Methods: A total of 513 blood samples (131 positive, 382 negative for SARS-CoV-2) were collected and tested by microneutralization test (MNT). Antigen stock of SARS-CoV-2 was prepared by propagating the virus in Vero CCL-81 cells. An IgG capture ELISA was developed for serological detection of anti-SARS-CoV-2 IgG in serum samples. The end point cut-off values were determined by using receiver operating characteristic (ROC) curve. Inter-assay variability was determined. Results: The developed ELISA was found to be 92.37 per cent sensitive, 97.9 per cent specific, robust and reproducible. The positive and negative predictive values were 94.44 and 98.14 per cent, respectively. Interpretation & conclusions: This indigenously developed IgG ELISA was found to be sensitive and specific for the detection of anti-SARS-CoV-2 IgG in human serum samples. This assay may be used for determining seroprevalence of SARS-CoV-2 in a population exposed to the virus.
      Citation: Indian Journal of Medical Research 2020 151(5):444-449
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_2232_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries
           reveals selective sweep of one virus type

    • Authors: Nidhan K Biswas, Partha P Majumder
      Pages: 450 - 458
      Abstract: Nidhan K Biswas, Partha P Majumder
      Indian Journal of Medical Research 2020 151(5):450-458
      Background & objectives: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus-2) is evolving with the progression of the pandemic. This study was aimed to investigate the diversity and evolution of the coronavirus SARS-CoV-2 with progression of the pandemic over time and to identify similarities and differences of viral diversity and evolution across geographical regions (countries).Methods: Publicly available data on type definitions based on whole-genome sequences of the SARS-CoV-2 sampled during December and March 2020 from 3636 infected patients spread over 55 countries were collected. Phylodynamic analyses were performed and the temporal and spatial evolution of the virus was examined.Results: It was found that (i) temporal variation in frequencies of types of the coronavirus was significant; ancestral viruses of type O were replaced by evolved viruses belonging to type A2a; (ii) spatial variation was not significant; with the spread of SARS-CoV-2, the dominant virus was the A2a type virus in every geographical region; (iii) within a geographical region, there was significant micro-level variation in the frequencies of the different viral types, and (iv) the evolved coronavirus of type A2a swept rapidly across all continents.Interpretation & conclusions: SARS-CoV-2 belonging to the A2a type possesses a non-synomymous variant (D614G) that possibly eases the entry of the virus into the lung cells of the host. This may be the reason why the A2a type has an advantage to infect and survive and as a result has rapidly swept all geographical regions. Therefore, large-scale sequencing of coronavirus genomes and, as required, of host genomes should be undertaken in India to identify regional and ethnic variation in viral composition and its interaction with host genomes. Further, careful collection of clinical and immunological data of the host can provide deep learning in relation to infection and transmission of the types of coronavirus genomes.
      Citation: Indian Journal of Medical Research 2020 151(5):450-458
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1125_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Healthcare workers & SARS-CoV-2 infection in India: A case-control
           investigation in the time of COVID-19

    • Authors: Pranab Chatterjee, Tanu Anand, Kh Jitenkumar Singh, Reeta Rasaily, Ravinder Singh, Santasabuj Das, Harpreet Singh, Ira Praharaj, Raman R Gangakhedkar, Balram Bhargava, Samiran Panda
      Pages: 459 - 467
      Abstract: Pranab Chatterjee, Tanu Anand, Kh Jitenkumar Singh, Reeta Rasaily, Ravinder Singh, Santasabuj Das, Harpreet Singh, Ira Praharaj, Raman R Gangakhedkar, Balram Bhargava, Samiran Panda
      Indian Journal of Medical Research 2020 151(5):459-467
      Background & objectives: Healthcare workers (HCWs) are at an elevated risk of contracting COVID-19. While intense occupational exposure associated with aerosol-generating procedures underlines the necessity of using personal protective equipment (PPE) by HCWs, high-transmission efficiency of the causative agent [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] could also lead to infections beyond such settings. Hydroxychloroquine (HCQ), a repurposed antimalarial drug, was empirically recommended as prophylaxis by the National COVID-19 Task Force in India to cover such added risk. Against this background, the current investigation was carried out to identify the factors associated with SARS-CoV-2 infection among HCWs in the country.Methods: A case-control design was adopted and participants were randomly drawn from the countrywide COVID-19 testing data portal maintained by the ICMR. The test results and contact details of HCWs, diagnosed as positive (cases) or negative (controls) for SARS-CoV-2 using real-time reverse transcription-polymerase chain reaction (qRT-PCR), were available from this database. A 20-item brief-questionnaire elicited information on place of work, procedures conducted and use of PPE.Results: Compared to controls, cases were slightly older (34.7 vs. 33.5 yr) and had more males (58 vs. 50%). In multivariate analyses, HCWs performing endotracheal intubation had higher odds of being SARS-CoV-2 infected [adjusted odds ratio (AOR): 4.33, 95% confidence interval (CI): 1.16-16.07]. Consumption of four or more maintenance doses of HCQ was associated with a significant decline in the odds of getting infected (AOR: 0.44; 95% CI: 0.22-0.88); a dose-response relationship existed between frequency of exposure to HCQ and such reductions (χ[2] for trend=48.88; P <0.001). In addition, the use of PPE was independently associated with the reduction in odds of getting infected with SARS-CoV-2.Interpretations & conclusions: Until results of clinical trials for HCQ prophylaxis become available, this study provides actionable information for policymakers to protect HCWs at the forefront of COVID-19 response. The public health message of sustained intake of HCQ prophylaxis as well as appropriate PPE use need to be considered in conjunction with risk homoeostasis operating at individual levels.
      Citation: Indian Journal of Medical Research 2020 151(5):459-467
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_2234_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • An overview of mobile applications (apps) to support the coronavirus
           disease 2019 response in India

    • Authors: Abhinav Bassi, Sumaiya Arfin, Oommen John, Vivekanand Jha
      Pages: 468 - 473
      Abstract: Abhinav Bassi, Sumaiya Arfin, Oommen John, Vivekanand Jha
      Indian Journal of Medical Research 2020 151(5):468-473
      Background & objectives: The potential benefits of mobile health (mHealth) initiatives to manage the coronavirus disease 2019 (COVID-19) pandemic have been explored. The Government of India, State governments, and healthcare organizations have developed various mobile apps for the containment of COVID-19. This study was aimed to systematically review COVID-19 related mobile apps and highlight gaps to inform the development of future mHealth initiatives. Methods: Google Play and the Apple app stores were searched using the terms 'COVID-19', 'coronavirus', 'pandemic', and 'epidemic' in the first week of April 2020. A list of COVID-19-specific functions was compiled based on the review of the selected apps, the literature on epidemic surveillance, and national and international media reports. The World Health Organization guideline on Digital Health Interventions was used to classify the app functions under the categories of the general public, health workers, health system managers, and data services. Results: The search yielded 346 potential COVID-19 apps, of which 50 met the inclusion criteria. Dissemination of untargeted COVID-19-related information on preventative strategies and monitoring the movements of quarantined individuals was the function of 27 (54%) and 19 (32%) apps, respectively. Eight (16%) apps had a contact tracing and hotspot identification function.Interpretation & conclusions: Our study highlights the current emphasis on the development of self-testing, quarantine monitoring, and contact tracing apps. India's response to COVID-19 can be strengthened by developing comprehensive mHealth solutions for frontline healthcare workers, rapid response teams and public health authorities. Among this unprecedented global health emergency, the Governments must ensure the necessary but least intrusive measures for disease surveillance.
      Citation: Indian Journal of Medical Research 2020 151(5):468-473
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1200_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Mapping the genomic landscape & diversity of COVID-19 based on
           >3950 clinical isolates of SARS-CoV-2: Likely origin &
           transmission dynamics of isolates sequenced in India

    • Authors: Hina Singh, Jasdeep Singh, Mohd Khubaib, Salma Jamal, Javaid Ahmed Sheikh, Sunil Kohli, Seyed Ehtesham Hasnain, Syed Asad Rahman
      Pages: 474 - 478
      Abstract: Hina Singh, Jasdeep Singh, Mohd Khubaib, Salma Jamal, Javaid Ahmed Sheikh, Sunil Kohli, Seyed Ehtesham Hasnain, Syed Asad Rahman
      Indian Journal of Medical Research 2020 151(5):474-478

      Citation: Indian Journal of Medical Research 2020 151(5):474-478
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1253_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Evaluation of the susceptibility of mice &#38; hamsters to
           SARS-CoV-2 infection

    • Authors: Sreelekshmy Mohandas, Rajlaxmi Jain, Pragya D Yadav, Anita Shete-Aich, Prasad Sarkale, Manoj Kadam, Abhimanyu Kumar, Gururaj Deshpande, Shreekant Baradkar, Savita Patil, Gajanan Sapkal, Deepak Mali, Malvika Salve, Dilip Patil, Triparna Majumdar, Annasaheb Suryawanshi, Himanshu Kaushal, Rajen Lakra, Hitesh Dighe, Nivedita Gupta, Priya Abraham, Raman R Gangakhedkar
      Pages: 479 - 482
      Abstract: Sreelekshmy Mohandas, Rajlaxmi Jain, Pragya D Yadav, Anita Shete-Aich, Prasad Sarkale, Manoj Kadam, Abhimanyu Kumar, Gururaj Deshpande, Shreekant Baradkar, Savita Patil, Gajanan Sapkal, Deepak Mali, Malvika Salve, Dilip Patil, Triparna Majumdar, Annasaheb Suryawanshi, Himanshu Kaushal, Rajen Lakra, Hitesh Dighe, Nivedita Gupta, Priya Abraham, Raman R Gangakhedkar
      Indian Journal of Medical Research 2020 151(5):479-482

      Citation: Indian Journal of Medical Research 2020 151(5):479-482
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_2235_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for
           confirmation of SARS-CoV-2 infection: An observational study

    • Authors: K Alagarasu, ML Choudhary, KS Lole, Priya Abraham, Varsha Potdar
      Pages: 483 - 485
      Abstract: K Alagarasu, ML Choudhary, KS Lole, Priya Abraham, Varsha Potdar
      Indian Journal of Medical Research 2020 151(5):483-485

      Citation: Indian Journal of Medical Research 2020 151(5):483-485
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1256_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Respiratory virus detection among the overseas returnees during the early
           phase of COVID-19 pandemic in India

    • Authors: Varsha Potdar, Manohar L Choudhary, Sumit Bhardwaj, Rohan Ghuge, AP Sugunan, Yogesh Gurav, Pragya D Yadav, Anita Shete, Shilpa Tomar, B Anukumar, Himanshu Kaushal, Gajanan Sapkal, Atanu Basu, Sarah Cherian, Priya Abraham
      Pages: 486 - 489
      Abstract: Varsha Potdar, Manohar L Choudhary, Sumit Bhardwaj, Rohan Ghuge, AP Sugunan, Yogesh Gurav, Pragya D Yadav, Anita Shete, Shilpa Tomar, B Anukumar, Himanshu Kaushal, Gajanan Sapkal, Atanu Basu, Sarah Cherian, Priya Abraham
      Indian Journal of Medical Research 2020 151(5):486-489

      Citation: Indian Journal of Medical Research 2020 151(5):486-489
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_638_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • First confirmed case of COVID-19 infection in India: A case report

    • Authors: MA Andrews, Binu Areekal, KR Rajesh, Jijith Krishnan, R Suryakala, Biju Krishnan, CP Muraly, PV Santhosh
      Pages: 490 - 492
      Abstract: MA Andrews, Binu Areekal, KR Rajesh, Jijith Krishnan, R Suryakala, Biju Krishnan, CP Muraly, PV Santhosh
      Indian Journal of Medical Research 2020 151(5):490-492

      Citation: Indian Journal of Medical Research 2020 151(5):490-492
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_2131_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • A confirmed case of COVID-19 among the first three from Kerala, India

    • Authors: Raman Swathy Vaman, Mathew J Valamparampil, AV Ramdas, AT Manoj, Basil Varghese, Flory Joseph
      Pages: 493 - 494
      Abstract: Raman Swathy Vaman, Mathew J Valamparampil, AV Ramdas, AT Manoj, Basil Varghese, Flory Joseph
      Indian Journal of Medical Research 2020 151(5):493-494

      Citation: Indian Journal of Medical Research 2020 151(5):493-494
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_2205_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity
           beyond diagnostics

    • Authors: Bhagirathi Dwibedi
      Pages: 495 - 496
      Abstract: Bhagirathi Dwibedi
      Indian Journal of Medical Research 2020 151(5):495-496

      Citation: Indian Journal of Medical Research 2020 151(5):495-496
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1548_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Authors&#39; response

    • Authors: Nivedita Gupta, Varsha Potdar, Ira Praharaj, Sidhartha Giri, Gajanan Sapkal, Pragya Yadav, Manohar Lal Choudhary, Lalit Dar, AP Sugunan, Harmanmeet Kaur, Ashok Munivenkatappa, Jayanthi Shastri, Krishnasamy Kaveri, Shanta Dutta, Bharti Malhotra, Amita Jain, Kammilli Nagamani, GB Shantala, Sharmila Raut, MM Vegad, Ajanta Sharma, Aashish Choudhary, Megha Brijwa, Anukumar Balakrishnan, Jayaswamy Manjunatha, Manish Pathak, Sivasubramanian Srinivasan, Hasina Banu, Himanshu Sharma, Parul Jain, Pakalpati Sunita, R Ambica, Babita Fageria, Disha Patel, Gitika Rajbongshi, Neetu Vijay, Jitendra Narayan, Neeraj Aggarwal, Anu Nagar, Raman R Gangakhedkar, Priya Abraham
      Pages: 496 - 496
      Abstract: Nivedita Gupta, Varsha Potdar, Ira Praharaj, Sidhartha Giri, Gajanan Sapkal, Pragya Yadav, Manohar Lal Choudhary, Lalit Dar, AP Sugunan, Harmanmeet Kaur, Ashok Munivenkatappa, Jayanthi Shastri, Krishnasamy Kaveri, Shanta Dutta, Bharti Malhotra, Amita Jain, Kammilli Nagamani, GB Shantala, Sharmila Raut, MM Vegad, Ajanta Sharma, Aashish Choudhary, Megha Brijwa, Anukumar Balakrishnan, Jayaswamy Manjunatha, Manish Pathak, Sivasubramanian Srinivasan, Hasina Banu, Himanshu Sharma, Parul Jain, Pakalpati Sunita, R Ambica, Babita Fageria, Disha Patel, Gitika Rajbongshi, Neetu Vijay, Jitendra Narayan, Neeraj Aggarwal, Anu Nagar, Raman R Gangakhedkar, Priya Abraham
      Indian Journal of Medical Research 2020 151(5):496-496

      Citation: Indian Journal of Medical Research 2020 151(5):496-496
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/0971-5916.286255
      Issue No: Vol. 151, No. 5 (2020)
       
  • Creation of a network of tropical medicine units to implement
           &#39;One Health&#39;

    • Authors: Sunil Kumar Raina
      Pages: 497 - 498
      Abstract: Sunil Kumar Raina
      Indian Journal of Medical Research 2020 151(5):497-498

      Citation: Indian Journal of Medical Research 2020 151(5):497-498
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1622_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Author&#39;s response

    • Authors: Rajesh Bhatia
      Pages: 498 - 498
      Abstract: Rajesh Bhatia
      Indian Journal of Medical Research 2020 151(5):498-498

      Citation: Indian Journal of Medical Research 2020 151(5):498-498
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/0971-5916.286414
      Issue No: Vol. 151, No. 5 (2020)
       
  • Community engagement in times of COVID-19: Lessons from neo-Vaishnavite
           practices

    • Authors: Bishwajeet Saikia, Raktim Pratim Tamuli, Dewark Sharma
      Pages: 499 - 500
      Abstract: Bishwajeet Saikia, Raktim Pratim Tamuli, Dewark Sharma
      Indian Journal of Medical Research 2020 151(5):499-500

      Citation: Indian Journal of Medical Research 2020 151(5):499-500
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1765_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Author&#39;s response

    • Authors: Rajesh Bhatia
      Pages: 500 - 501
      Abstract: Rajesh Bhatia
      Indian Journal of Medical Research 2020 151(5):500-501

      Citation: Indian Journal of Medical Research 2020 151(5):500-501
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/0971-5916.286494
      Issue No: Vol. 151, No. 5 (2020)
       
  • Infectious disease isolation facility with advanced engineering design:
           Need of the hour

    • Authors: Bhagirathi Dwibedi
      Pages: 502 - 503
      Abstract: Bhagirathi Dwibedi
      Indian Journal of Medical Research 2020 151(5):502-503

      Citation: Indian Journal of Medical Research 2020 151(5):502-503
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/ijmr.IJMR_1657_20
      Issue No: Vol. 151, No. 5 (2020)
       
  • Authors&#39; response

    • Authors: Anup Agarwal, Nazia Nagi, Pranab Chatterjee, Swarup Sarkar, Devendra Mourya, Rima Rakeshkumar Sahay, Rajesh Bhatia
      Pages: 503 - 504
      Abstract: Anup Agarwal, Nazia Nagi, Pranab Chatterjee, Swarup Sarkar, Devendra Mourya, Rima Rakeshkumar Sahay, Rajesh Bhatia
      Indian Journal of Medical Research 2020 151(5):503-504

      Citation: Indian Journal of Medical Research 2020 151(5):503-504
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/0971-5916.286224
      Issue No: Vol. 151, No. 5 (2020)
       
  • Erratum: Guidance for building a dedicated health facility to contain the
           spread of the 2019 novel coronavirus outbreak

    • Pages: 504 - 504
      Abstract:
      Indian Journal of Medical Research 2020 151(5):504-504

      Citation: Indian Journal of Medical Research 2020 151(5):504-504
      PubDate: Sat,20 Jun 2020
      DOI: 10.4103/0971-5916.287328
      Issue No: Vol. 151, No. 5 (2020)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.235.74.77
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-